Phio Pharmaceuticals Corp. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Phio Pharmaceuticals Corp. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2024.
  • Phio Pharmaceuticals Corp. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 958K shares, a 58.5% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 958K -1.35M -58.5% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 510K -1.48M -74.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.59M +3.44M +299% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 416K -723K -63.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 2.31M -11.4M -83.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.99M -11.7M -85.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 1.15M -12.5M -91.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 1.14M +11.1K +0.99% Dec 31, 2022 10-K 2024-04-01
Q3 2022 13.7M +133K +0.99% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 13.7M +124K +0.92% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 13.7M +124K +0.92% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 1.13M -4.65M -80.5% Dec 31, 2021 10-K 2023-03-22
Q3 2021 13.5M +7.75M +134% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 13.5M +7.75M +134% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 13.5M +10.7M +372% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 5.78M +5.11M +764% Dec 31, 2020 10-K 2022-03-22
Q3 2020 5.78M -19.9M -77.5% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 5.78M -19.3M -77% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 2.87M -20.5M -87.7% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 669K +327K +95.4% Dec 31, 2019 10-K 2021-03-25
Q3 2019 25.7M +21.2M +477% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 25.1M +20.7M +475% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 23.4M +20.7M +766% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 343K -2.09M -85.9% Dec 31, 2018 10-K 2020-03-26
Q3 2018 4.45M +2.08M +87.8% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 4.36M +2.04M +87.6% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 2.7M +495K +22.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 2.43M 0 0% Dec 31, 2017 10-K 2019-03-27
Q3 2017 2.37M -4.23M -64.1% Sep 30, 2017 10-Q/A 2018-03-26
Q2 2017 2.32M -4.21M -64.4% Jun 30, 2017 10-Q/A 2018-03-26
Q1 2017 2.2M -4.33M -66.3% Mar 31, 2017 10-Q/A 2018-03-26
Q4 2016 2.43M -4.1M -62.8% Dec 31, 2016 10-K 2018-03-26
Q3 2016 6.6M -58.3M -89.8% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 6.53M -58.4M -89.9% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 6.53M -24.7M -79.1% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 6.53M -15.4M -70.3% Dec 31, 2015 10-K 2017-03-30
Q3 2015 64.9M +43.8M +207% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 64.9M +50M +336% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 31.2M +17.8M +133% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 22M 0 0% Dec 31, 2014 10-K 2016-03-30
Q3 2014 21.1M +9.45M +80.9% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 14.9M +3.46M +30.2% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 13.4M -308M -95.8% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 22M +16.7M +316% Dec 31, 2013 10-K 2015-03-30
Q3 2013 11.7M -146M -92.6% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 11.4M -145M -92.7% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 322M +221M +220% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 5.29M -95.2M -94.7% Dec 31, 2012 10-K 2014-03-28
Q3 2012 158M Sep 30, 2012 10-Q 2012-11-13
Q2 2012 156M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 100M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 100M Dec 31, 2011 10-K 2013-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.